<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36238713</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2022.10.06.22280795</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2022.10.06.22280795</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Characterizing the effect of vaccination on long COVID allows for better healthcare recommendations.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To determine if, and to what degree, vaccination prior to COVID-19 is associated with eventual long COVID onset, among those a documented COVID-19 infection.</AbstractText><AbstractText Label="DESIGN SETTINGS AND PARTICIPANTS" NlmCategory="UNASSIGNED">Retrospective cohort study of adults with evidence of COVID-19 between August 1, 2021 and January 31, 2022 based on electronic health records from eleven healthcare institutions taking part in the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, a project of the National Covid Cohort Collaborative (N3C).</AbstractText><AbstractText Label="EXPOSURES" NlmCategory="UNASSIGNED">Pre-COVID-19 receipt of a complete vaccine series versus no pre-COVID-19 vaccination.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Two approaches to the identification of long COVID were used. In the clinical diagnosis cohort (n=47,752), ICD-10 diagnosis codes or evidence of a healthcare encounter at a long COVID clinic were used. In the model-based cohort (n=199,498), a computable phenotype was used. The association between pre-COVID vaccination and long COVID was estimated using IPTW-adjusted logistic regression and Cox proportional hazards.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In both cohorts, when adjusting for demographics and medical history, pre-COVID vaccination was associated with a reduced risk of long COVID (clinic-based cohort: HR, 0.66; 95% CI, 0.55-0.80; OR, 0.69; 95% CI, 0.59-0.82; model-based cohort: HR, 0.62; 95% CI, 0.56-0.69; OR, 0.70; 95% CI, 0.65-0.75).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">Long COVID has become a central concern for public health experts. Prior studies have considered the effect of vaccination on the prevalence of future long COVID symptoms, but ours is the first to thoroughly characterize the association between vaccination and clinically diagnosed or computationally derived long COVID. Our results bolster the growing consensus that vaccines retain protective effects against long COVID even in breakthrough infections.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="UNASSIGNED"><b>Question:</b> Does vaccination prior to COVID-19 onset change the risk of long COVID diagnosis?<b>Findings:</b> Four observational analyses of EHRs showed a statistically significant reduction in long COVID risk associated with pre-COVID vaccination (first cohort: HR, 0.66; 95% CI, 0.55-0.80; OR, 0.69; 95% CI, 0.59-0.82; second cohort: HR, 0.62; 95% CI, 0.56-0.69; OR, 0.70; 95% CI, 0.65-0.75).<b>Meaning:</b> Vaccination prior to COVID onset has a protective association with long COVID even in the case of breakthrough infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brannock</LastName><ForeName>M Daniel</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>RTI International, Durham, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>RTI International, Durham, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preiss</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>RTI International, Durham, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadley</LastName><ForeName>Emily C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>RTI International, Durham, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Denver, CO, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leese</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Palantir Technologies, Denver, CO, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crosskey</LastName><ForeName>Miles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CoVar Applied Technologies, Durham, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Andrea G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>University of Virginia, Charlottesville, VA, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Stony Brook University, Stony Brook, NY, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funk</LastName><ForeName>Michele Jonsson</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Denver, CO, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C and RECOVER Consortia </CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Nat Commun. 2023 May 22;14(1):2914. doi: 10.1038/s41467-023-38388-7</RefSource><PMID Version="1">37217471</PMID></CommentsCorrections></CommentsCorrectionsList><InvestigatorList><Investigator ValidYN="Y"><LastName>St&#xfc;rmer</LastName><ForeName>Til</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, Chapel Hill, NC, US.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Loomba</LastName><ForeName>Johanna J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>University of Virginia, Charlottesville, VA, US.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koraishy</LastName><ForeName>Farrukh M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Stony Brook Medicine, Stony Brook, NY, US.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>3</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36238713</ArticleId><ArticleId IdType="pmc">PMC9558440</ArticleId><ArticleId IdType="doi">10.1101/2022.10.06.22280795</ArticleId><ArticleId IdType="pii">2022.10.06.22280795</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC. CDC Museum COVID-19 Timeline. Centers for Disease Control and Prevention. Published
August
16, 2022. Accessed
September 6, 2022. https://www.cdc.gov/museum/timeline/covid19.html</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. Accessed
August 26, 2022. https://covid19.who.int/</Citation></Reference><Reference><Citation>Lerner AM, Robinson DA, Yang L, et al. Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19. Ann Intern Med. 2021;174(7):999&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325(19):2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Patel MM, Ginde AA, et al. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. medRxiv. Published online July 8, 2021. doi:10.1101/2021.07.08.21259776</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.08.21259776</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network. Open Forum Infect Dis. 2022;9(7):ofac228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MA, Luginbuhl RD, Parker R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. bioRxiv. Published online November 18, 2021. doi:10.1101/2021.11.17.21263608</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al. Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19. bioRxiv. Published online January 8, 2022. doi:10.1101/2022.01.04.21268536</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.04.21268536</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, Han AX, Boyd A, et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine. 2022;40(32):4424&#x2013;4431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M, Pijnenburg L, Chatelus E, et al. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study. Vaccines (Basel). 2021;10(1). doi:10.3390/vaccines10010046</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, et al. Association of Vaccination with the Persistence of Post-COVID Symptoms. J Gen Intern Med. 2022;37(7):1748&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. The Lancet Digital Health. 2022;4(7):e532&#x2013;e541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVER: Researching COVID to Enhance Recovery. RECOVER: Researching COVID to Enhance Recovery. Accessed
September 6, 2022. https://recovercovid.org/</Citation></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28(3):427&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Gabriel DL, et al. Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative. J Am Med Inform Assoc. 2022;29(4):609&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500110</ArticleId><ArticleId IdType="pubmed">34590684</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JC, Conover MM, Funk MJ. Measurement error and misclassification in electronic medical records: methods to mitigate bias. Curr Epidemiol Rep. 2018;5(4):343&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9141310</ArticleId><ArticleId IdType="pubmed">35633879</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID-19 Vaccination Data in the United States. Centers for Disease Control and Prevention. Published
April
29, 2022. Accessed
March 23, 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/distributing/about-vaccine-data.html</Citation></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Robins JM, Hern&#xe1;n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">10955408</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med. 2016;35(30):5642&#x2013;5655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5157758</ArticleId><ArticleId IdType="pubmed">27549016</ArticleId></ArticleIdList></Reference><Reference><Citation>CoxPHFitter &#x2014; lifelines 0.27.1 documentation.
Accessed
September 6, 2022. https://lifelines.readthedocs.io/en/latest/fitters/regression/CoxPHFitter.html</Citation></Reference><Reference><Citation>Park S, Hendry DJ. Reassessing Schoenfeld residual tests of proportional hazards in political science event history analyses. Am J Pol Sci. 2015;59(4):1072&#x2013;1087.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Bhavsar NA, Phelan M, Pencina MJ. Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record. Am J Epidemiol. 2016;184(11):847&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5152663</ArticleId><ArticleId IdType="pubmed">27852603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring AS, Tenforde MW, Chappell JD, et al. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study. medRxiv. Published online February 7, 2022. doi:10.1101/2022.02.06.22270558</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.06.22270558</ArticleId><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N, Stowe J, Kirsebom F, et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022;386(16):1532&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908811</ArticleId><ArticleId IdType="pubmed">35249272</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID Data Tracker. COVID Data Tracker. Accessed
September 6, 2022. https://covid.cdc.gov/covid-data-tracker/#variant-proportions</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>